醫療保健消費與藥物

繁體中文

醫務衞生局及衞生署藥物辦公室發布官方資料。本地醫療衞生經費在2023-24年度約佔 GDP 的 8.3%，反映總量開支水平。中藥方面，法定名錄列明 605 種中藥材（附表1劇性／烈性31種＋附表2常用574種）。 公營與私營醫療的資金流向比例、全港已註冊西藥總數，及「1+」新藥審批機制下獲批的新藥數目，目前未逐一收錄，屬延伸資料。醫療經費常以「佔GDP」表述，須與其他經濟體同一口徑比較方有意義。

English

The Health Bureau and the Department of Health's Drug Office publish official material. Total domestic health expenditure was about 8.3% of GDP in FY2023-24. For Chinese medicine, the statutory lists cover 605 herbal medicines (31 toxic/poisonous in Schedule 1 and 574 common in Schedule 2). The public/private split of health funding flows, the total number of registered Western medicines, and the count approved under the "1+" mechanism for new drugs are further data not yet catalogued. Health spending is usually quoted as a share of GDP and is only meaningful compared across economies on the same basis.